Search research articles
Contact Us
Filters
Showing results (931-940 of 967) with videos related to
Page
of 97
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
March 11, 2021
Hematological immune related adverse events after treatment with immune checkpoint inhibitors
Rafaela Kramer, Anne Zaremba, Alvaro Moreira, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 13, 2022
Genetic characterization of advanced conjunctival melanoma and response to systemic treatment
Georg C Lodde, Philipp Jansen, Inga Möller, et al.
International Journal of Cancer
|
May 18, 2004
A high proportion of founder BRCA1 mutations in Polish breast cancer families
Bohdan Górski, Anna Jakubowska, Tomasz Huzarski, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 28, 2025
Clinical outcomes and management following progressive disease with anti-PD-(L)1 therapy in patients with advanced Merkel Cell Carcinoma
Jeremy Mo, Anne Zaremba, Andrisha-Jade Inderjeeth, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 26, 2024
Outcomes of patients with resected stage III/IV acral or mucosal melanoma, treated with adjuvant anti-PD-1 based therapy
Sarah K Jacques, Janet McKeown, Piyush Grover, et al.
Frontiers in Oncology
|
November 8, 2021
Grade 4 Neutropenia Secondary to Immune Checkpoint Inhibition - A Descriptive Observational Retrospective Multicenter Analysis
Anne Zaremba, Rafaela Kramer, Viola De Temple, et al.
Science Advances
|
November 27, 2024
Genomic heterogeneity and ploidy identify patients with intrinsic resistance to PD-1 blockade in metastatic melanoma
Giuseppe Tarantino, Cora A Ricker, Annette Wang, et al.
Frontiers in Medicine
|
November 3, 2025
COVID-19 convalescent plasma for B-cell depleted patients: a systematic review and individual patient data meta-analysis
Solomiia Zaremba, Daniele Focosi, Wyatt W Pruter, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 23, 2025
First-line checkpoint inhibitor therapy in metastatic acral lentiginous melanoma compared to other types of cutaneous melanoma: A multicenter study from the prospective skin cancer registry ADOREG
Sören Reinhard, Jochen Sven Utikal, Anne Zaremba, et al.
Journal for Immunotherapy of Cancer
|
July 6, 2022
Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma
Prachi Bhave, Tasnia Ahmed, Serigne N Lo, et al.
Page
of 97
Search research articles
Search
Showing results (931-940 of 967) with videos related to
Sort By:
Page
of 97
European Journal of Cancer (Oxford, England : 1990)
|
March 11, 2021
Hematological immune related adverse events after treatment with immune checkpoint inhibitors
Rafaela Kramer, Anne Zaremba, Alvaro Moreira, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 13, 2022
Genetic characterization of advanced conjunctival melanoma and response to systemic treatment
Georg C Lodde, Philipp Jansen, Inga Möller, et al.
International Journal of Cancer
|
May 18, 2004
A high proportion of founder BRCA1 mutations in Polish breast cancer families
Bohdan Górski, Anna Jakubowska, Tomasz Huzarski, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 28, 2025
Clinical outcomes and management following progressive disease with anti-PD-(L)1 therapy in patients with advanced Merkel Cell Carcinoma
Jeremy Mo, Anne Zaremba, Andrisha-Jade Inderjeeth, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 26, 2024
Outcomes of patients with resected stage III/IV acral or mucosal melanoma, treated with adjuvant anti-PD-1 based therapy
Sarah K Jacques, Janet McKeown, Piyush Grover, et al.
Frontiers in Oncology
|
November 8, 2021
Grade 4 Neutropenia Secondary to Immune Checkpoint Inhibition - A Descriptive Observational Retrospective Multicenter Analysis
Anne Zaremba, Rafaela Kramer, Viola De Temple, et al.
Science Advances
|
November 27, 2024
Genomic heterogeneity and ploidy identify patients with intrinsic resistance to PD-1 blockade in metastatic melanoma
Giuseppe Tarantino, Cora A Ricker, Annette Wang, et al.
Frontiers in Medicine
|
November 3, 2025
COVID-19 convalescent plasma for B-cell depleted patients: a systematic review and individual patient data meta-analysis
Solomiia Zaremba, Daniele Focosi, Wyatt W Pruter, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 23, 2025
First-line checkpoint inhibitor therapy in metastatic acral lentiginous melanoma compared to other types of cutaneous melanoma: A multicenter study from the prospective skin cancer registry ADOREG
Sören Reinhard, Jochen Sven Utikal, Anne Zaremba, et al.
Journal for Immunotherapy of Cancer
|
July 6, 2022
Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma
Prachi Bhave, Tasnia Ahmed, Serigne N Lo, et al.
Page
of 97